- Clinical Trials
- April 2024
- 40 Pages
From €864EUR$875USD£721GBP
€1234EUR$1,250USD£1,031GBP
- Report
- March 2024
- 120 Pages
Global
From €5495EUR$5,565USD£4,589GBP
€7850EUR$7,950USD£6,555GBP
- Report
- March 2024
- 60 Pages
Global
From €2730EUR$2,765USD£2,280GBP
€3900EUR$3,950USD£3,257GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- November 2023
- 30 Pages
Global
From €2246EUR$2,275USD£1,876GBP
€3209EUR$3,250USD£2,680GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- November 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- November 2023
- 30 Pages
United States
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- November 2023
- 262 Pages
Global
From €5184EUR$5,250USD£4,329GBP
€7406EUR$7,500USD£6,184GBP
- Report
- February 2023
- 164 Pages
Global
From €5184EUR$5,250USD£4,329GBP
€7406EUR$7,500USD£6,184GBP
- Report
- February 2023
- 82 Pages
Global
From €2730EUR$2,765USD£2,280GBP
€3900EUR$3,950USD£3,257GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- August 2022
- 175 Pages
Global
From €6566EUR$6,650USD£5,483GBP
€9381EUR$9,500USD£7,833GBP
- Report
- August 2022
- 87 Pages
Global
From €3283EUR$3,325USD£2,742GBP
€4690EUR$4,750USD£3,917GBP
- Report
- July 2022
- 116 Pages
Global
From €5184EUR$5,250USD£4,329GBP
€7406EUR$7,500USD£6,184GBP
- Report
- July 2022
- 58 Pages
Global
From €2730EUR$2,765USD£2,280GBP
€3900EUR$3,950USD£3,257GBP
- Report
- July 2022
- 100 Pages
Global
From €1901EUR$1,925USD£1,587GBP
€2715EUR$2,750USD£2,268GBP
- Report
- February 2022
- 149 Pages
Global
From €5184EUR$5,250USD£4,329GBP
€7406EUR$7,500USD£6,184GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €2730EUR$2,765USD£2,280GBP
€3900EUR$3,950USD£3,257GBP
The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market.
Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans.
Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more
